Safety and Immunogenicity of a ChAd155-Vectored Respiratory Syncytial Virus Vaccine in Infants 6-7 Months of age: A Phase 1/2 Randomized Trial.
J Infect Dis
; 229(1): 95-107, 2024 Jan 12.
Article
in En
| MEDLINE
| ID: mdl-37477875
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Respiratory Syncytial Virus, Human
/
Respiratory Syncytial Virus Infections
/
Respiratory Syncytial Virus Vaccines
Type of study:
Clinical_trials
Limits:
Humans
/
Infant
Language:
En
Journal:
J Infect Dis
Year:
2024
Document type:
Article
Country of publication: